Results 141 to 150 of about 1,078,128 (318)

Proportion of patients with concomitant therapies.

, 2019
The figure shows the proportion of patients taking one ore more concomitant medications in this real world cohort. Only 191 patients (14.4%) were not taking concomitant medications.
Domenico Potenza (5575022), Angelo Chimenti (6703832), Marina Cela (6703844), Sergio De Gioia (6703829), Giuseppe Cuccorese (648647), Michele Mazzola (5575025), Valeria Piazzolla (648637), Giuseppe Mennea (6703841), Ruggiero Losappio (6703847), Gianfranco Lauletta (5316209), Rosanna Santoro (5575046), Ernesto Agostinacchio (6703838), Massimiliano Copetti (174166), Anna Giannelli (6703814), Antonio Metrangolo (6703835), Alessandra Mangia (626370), Ernesto Piccigallo (6703826), Nicola Napoli (310693), Egidio Visaggi (6703817), Nicola Minerva (648643), Vincenzo Tagarielli (6703823), Vincenzo Palmieri (5575040), Carlo Sabbà (427739), Immacolata Carraturo (6703820)   +23 more
core   +1 more source

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

Cancer Medicine
Background Concomitant medications (CMs) influence outcomes in patients receiving immune checkpoint inhibitors (ICIs), but their impact in sarcoma remains undefined. We assessed the association between CM use and ICI outcomes in patients with advanced or
Adel Shahnam, Kristen DiConza, Simran Jasnani, Rhoena Desir‐Camille, Evan Rosenbaum, Olayode Babatunde, Ciara M. Kelly, Lauren B. Banks, Viswatej Avutu, Ping Chi, Sujana Movva, Mark A. Dickson, Mrinal M. Gounder, Mary L. Keohan, Robert G. Maki, William D. Tap, Sandra P. D'Angelo   +16 more
doaj   +1 more source

The human gut microbiome across the life course

FEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero, Basak Bahcivanci, Antonietta Hayhoe, Animesh Acharjee, Ezgi Özkurt   +4 more
wiley   +1 more source

Concomitant Lymphoma and Carcinoma

Annals of Saudi Medicine, 1991
M I, Yasawy, A R, Mohammed, M A, Al-Karawi, K H, Sidky, M, Jawdat   +4 more
openaire   +2 more sources

Degradation mechanism of the von Willebrand factor A2 domain by nattokinase

FEBS Letters, EarlyView.
Nattokinase, a natto‐derived protease, exhibits potent antithrombotic effects. This study demonstrates that nattokinase directly cleaves the von Willebrand factor (vWF) A2 domain in vitro. Unlike the native regulator ADAMTS13, nattokinase degrades folded vWF independently of shear stress.
Ryuichi Hyakumoto, Masatomo So, Ayako Furukawa, Kenji Sugase   +3 more
wiley   +1 more source

Salmonella lipopolysaccharide‐containing supported lipid bilayers as platforms to study bacteriophage interactions

FEBS Letters, EarlyView.
We present robust protocols for the preparation of supported lipid bilayers (SLBs) incorporating either Salmonella smooth LPS or outer membrane vesicles (OMVs). We use a combination of quartz crystal microbalance with dissipation (QCM‐D) and fluorescence microscopy to both characterize the SLBs of various compositions and to probe their interactions ...
Hudson P. Pace, Alyssa Borges, Charles Arnaud, Tove Karlsson, Nina K. Bröker, Stefanie Barbirz, Marta Bally   +6 more
wiley   +1 more source

CONCOMITANT STRABISMUS AND HETEROPHORIA [PDF]

American Journal of Optometry, 1928
openaire   +2 more sources

Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States

Journal of Pain Research
Gary Berman,1 Alexandra Thiry,2 Robert Croop3 1Clinical Research Institute, Minneapolis, MN, USA; 2Pfizer Inc., New York, NY, USA; 3Biohaven Pharmaceuticals, New Haven, CT, USACorrespondence: Gary Berman, Clinical Research Institute, 825 Nicollet Mall ...
Berman G, Thiry A, Croop R
doaj  

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

FEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Whole-exome sequencing uncovers the genetic basis of hereditary concomitant exotropia in ten Chinese pedigrees

BMC Medical Genomics
Purpose To explore possible pathogenic genes for concomitant exotropia using whole-exome sequencing. Methods In this study, 47 individuals from 10 concomitant exotropia (including intermittent exotropia and constant exotropia) pedigrees were enrolled ...
Wenhua Duan, Taicheng Zhou, Xiaoru Huang, Dongqiong He, Min Hu   +4 more
doaj   +1 more source